Albert Bourla, CEO of Pfizer attends a dialogue on the World Financial Discussion board (WEF) in Davos, Switzerland Could 25, 2022. REUTERS/Arnd Wiegmann
Sept 24 (Reuters) – Pfizer Inc (PFE.N) Chief Government Officer Albert Bourla mentioned on Saturday he had examined optimistic for COVID-19.
“I’m feeling effectively and symptom free,” Bourla mentioned in a press release.
Bourla, 60, again in August had contacted COVID and had began a course of the corporate’s oral COVID-19 antiviral remedy, Paxlovid. learn extra
Paxlovid is an antiviral treatment that’s used to deal with high-risk individuals, akin to older sufferers.
Bourla has acquired 4 doses of the COVID vaccine developed by Pfizer and its German companion BioNTech (22UAy.DE).
The chief government mentioned he has not but taken the brand new bivalent booster.
Developed by Moderna and the group of Pfizer and BioNTech, the brand new so-called bivalent photographs goal to deal with the BA.5 and BA.4 Omicron subvariants, which make up 84.8% and 1.8%, respectively, of all circulating variants in the USA, primarily based on newest knowledge.
“I’ve not had the brand new bivalent booster but, as I used to be following CDC tips to attend three months since my earlier COVID case which was again in mid-August,” Bourla added.
In August, the FDA licensed Pfizer and Moderna’s up to date booster photographs that focus on the dominant BA.4 and BA.5 Omicron subvariants.
A federal well being company mentioned this week that over 25 million doses of the so-called bivalent photographs had been despatched out. That consisted of largely the Pfizer/BioNTech vaccine, as manufacturing of the Moderna vaccine ramps up. learn extra
Reporting by Mrinmay Dey in Bengaluru; Enhancing by Daniel Wallis
: .
